Authors

Benefit of Clobetasol Propionate Post-Cataract Surgery, With Jeffrey Levenson, MD

Jeffrey Levenson, MD, discusses the sustained reduction of ocular inflammation and pain post ocular surgery with clobetasol propionate ophthalmic suspension.

Etrasimod: A New Oral Treatment Option for Ulcerative Colitis

The S1PR modulators are currently positioned to serve as a great treatment option for patients with moderate disease who are hesitant to escalate to a biologic treatment.

Embracing change in the new era of type 2 diabetes care

How Climate Change is Making Allergies Worse—And What Clinicians Can Do

Climate change worsens allergies by lengthening pollen seasons, increasing air pollution, and driving new food allergies. Experts offer strategies for clinicians.

Fenofibrates in the Treatment of Primary Biliary Cholangitis

New data suggest adding fibrate therapy to frontline PBC treatment could result in earlier and higher rates of biochemical response.

BELIEVE: Bimagrumab/Semaglutide Combo Yields Substantial Fat Mass Weight Loss, Preserves Lean Mass

The combination was significantly more efficacious than either therapy alone on both body composition and physical activity; safety events were similar across study arms and consistent with known profiles.

Helping Schools Calculate Respiratory Infection Risk

Wilson details how her team plans to develop risk assessment models to estimate respiratory viral infection risk reductions for interventions in elementary schools.

Discussing Remibrutinib Following FDA Approval for CSU, With Adam Friedman, MD

This interview highlights the significance of remibrutinib's recent FDA approval for clinicians treating chronic spontaneous urticaria.